Rationalisation and bankruptcy take their toll in 2003
This article was originally published in Clinica
Executive Summary
For many smaller firms, rationalisation was the order of the day in 2003, and some failed to weather the cash crunch. Meanwhile, major scandals were mercifully few and far between, with Abbott in enteral nutrition marketing, Guidant in abdominal aortic aneurysm devices and Jomed - whose financial misdoings led to its downfall - representing the main exceptions. Eleanor Malone reports